Key result
The PFA-100/200 is a valuable tool for screening and monitoring primary hemostasis disorders, though its closure time results lack specificity for individual conditions.
Design
Review
Authors
Loading...
May aid screening but not diagnosis of primary hemostasis disorders; leaves open prospective validation of integrated algorithms.
The PFA-100/200 is a useful global screening tool for primary hemostasis disorders and monitoring therapy, though it lacks diagnostic specificity.
Emmanuel J. Favaloro (2016) conducted a review in von Willebrand Disease (VWD) and platelet disorders. Platelet function analyzer (PFA)-100/200 was evaluated. The PFA-100/200 is a valuable tool for screening and monitoring primary hemostasis disorders, though its closure time results lack specificity for individual conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: